These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Irreversible enzyme inhibitors. LXXII. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. VI. Derivatives of hydrophobically bonded p-alkyl and p-aralkyl benzoic acids. Baker BR; Schwan TJ; Ho BT J Pharm Sci; 1967 Jan; 56(1):38-42. PubMed ID: 6030491 [No Abstract] [Full Text] [Related]
7. Irreversible enzyme inhibitors. LXXXVII. Hydrophobic bonding to dihydrofolic reductase. IX. Mode of binding of m-aryloxyalkyl groups on 4,6-diamino-1,2-dihdro-2,2-dimethyl-1-phenyl-s-triazine. Baker BR; Lourens GJ J Pharm Sci; 1967 Jul; 56(7):871-5. PubMed ID: 6068108 [No Abstract] [Full Text] [Related]
8. Inhibitor binding analysis of dihydrofolate reductases from various species. Burchall JJ; Hitchings GH Mol Pharmacol; 1965 Sep; 1(2):126-36. PubMed ID: 4378654 [No Abstract] [Full Text] [Related]
9. Analogs of tetrahydrofolic acid. 33. Hydrophobic bonding to dihydrofolic reductase V. Inhibition by some pyrimidines bridged to benzoic acid. Baker BR; Ho BT; Coward JK; Santi DV J Pharm Sci; 1966 Mar; 55(3):302-8. PubMed ID: 5960176 [No Abstract] [Full Text] [Related]
10. Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse. Baker BR; Lourens GJ; Meyer RB; Vermeulen NM J Med Chem; 1969 Jan; 12(1):67-73. PubMed ID: 5763043 [No Abstract] [Full Text] [Related]
11. Analogs of tetrahydrofolic acid 34. Hydrophobic bonding to dihydrofolic reductase VI. Mode of phenyl binding of some 6-arylpyrimidines. Baker BR; Shapiro HS J Pharm Sci; 1966 Mar; 55(3):308-17. PubMed ID: 5960177 [No Abstract] [Full Text] [Related]
12. Studies on dihydrofolic reductase. I. Purification and properties of dihydrofolic reductase from chicken liver. Kaufman BT; Gardiner RC J Biol Chem; 1966 Mar; 241(6):1319-28. PubMed ID: 4379915 [No Abstract] [Full Text] [Related]
13. Irreversible enzyme inhibitors. 158. Effect of bridge modification on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenzamidomethyl)phenoxymethyl]pyrimidine. II. Baker BR; Vermuelen NM J Med Chem; 1969 Jul; 12(4):684-8. PubMed ID: 5793162 [No Abstract] [Full Text] [Related]